Please use this identifier to cite or link to this item:
Type
ArticleCopyright
Restricted access
Embargo date
2030-01-01
Collections
- CDTS - Artigos de Periódicos [472]
- Farmanguinhos - Artigos de Periódicos [242]
- INI - Artigos de Periódicos [3498]
- IOC - Artigos de Periódicos [12791]
Metadata
Show full item record
2,8-BIS (TRIFLUOROMETHYL)QUINOLINE ANALOGS SHOW IMPROVED ANTI-ZIKA VIRUS ACTIVITY, COMPARED TO MEFLOQUINE
Author
Affilliation
Abstract
Zika virus (ZIKV), an arthropod-born Flavivirus, has been associated with a wide range of neurological diseases in adults, foetuses and neonates. Since no vaccine is available, repurposing of antiviral drugs currently in medical use is necessary. Mefloquine has confirmed anti-ZIKV activity. We used medicinal chemistry-driven approaches to synthesize and evaluate the ability of a series of new 2,8-bis(trifluoromethyl)quinoline derivatives to inhibit ZIKV replication in vitro, in order to improve the potency of mefloquine. We found that quinoline derivatives 3a and 4 were the most potent compounds within this series, both with mean EC50 values of 0.8 μM, which represents a potency 5 times that of mefloquine. These results indicate that new 2,8-bis(trifluoromethyl)quinoline chemical structures may be promising for the development of novel anti-ZIKV drugs.
Share